Amundi’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-5
Closed -$70 2120
2025
Q1
$70 Sell
5
-27
-84% -$378 ﹤0.01% 2171
2024
Q4
$769 Buy
+32
New +$769 ﹤0.01% 2050